离岸价格
获取最新报价120 ~ 150 USD / Box ( Negotiable )
|1 Box Minimum Order
国家:
China
型号:
-
离岸价格:
120 ~ 150 USD / Box ( Negotiable ) 获取最新报价
位置:
China
最小订单价格:
120 per Box
最小订单:
1 Box
包装细节:
foil bag
交货时间:
within 5 days
供应能力:
100 Box per Day
付款方式:
PayPal, T/T
產品組 :
-
联系人 Naomi
Xingtai, Hebei
Tirzepatide (LY******6) is a dual glucose-dependent insulinotropic
polypeptide (GIP) and glucagon-like peptide*1 (GLP*1) receptor
agonist.
This medication is designed to improve glycemic control in people
with type 2 diabetes by targeting both the GIP and GLP*1 receptors.
By stimulating these receptors, tirzepatide can increase insulin
secretion and decrease glucagon secretion in a glucose-dependent
manner, helping to lower blood sugar levels.
Clinical trials have shown promising results in terms of reducing
HbA1c levels and body weight in individuals with type 2 diabetes.
Tirzepatide is being studied in various dosages and formulations to
determine its effectiveness, safety, and potential benefits for
people with diabetes
NOTE: This product was prepared by chemical synthesis. Used only
for research. Not for human use.
| 国家: | China |
| 型号: | - |
| 离岸价格: | 120 ~ 150 / Box ( Negotiable ) 获取最新报价 |
| 位置: | China |
| 最小订单价格: | 120 per Box |
| 最小订单: | 1 Box |
| 包装细节: | foil bag |
| 交货时间: | within 5 days |
| 供应能力: | 100 Box per Day |
| 付款方式: | PayPal, T/T |
| 產品組 : | - |
